Ruzotolimod

N/A

Report date: 2026/05/20 20:02:01
NME

Base Information

Drug NameRuzotolimod
Drug Alias NameRO7020531RG-7854RO-7020531
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionToll like receptor 7 agonists
TargetsToll like receptor 7
Therapy Area/IndicationsHepatitis B, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBulgariaCanadaTaiwan +[15] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesF. Hoffmann-La Roche Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesF. Hoffmann-La Roche Ltd
Inactive CompaniesRoche R&D Center (China) Ltd
Active IndicationsHepatitis B, Chronic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A